Design, synthesis and biological evaluation of alkynyl-containing maleimide derivatives for the treatment of drug-resistant tuberculosis
- 15 November 2022
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 131, 106250
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Identification of an anti-inflammatory derivative with anti-cancer potential: The impact of each of its structural components on inflammatory responses in macrophages and bladder cancer cellsEuropean Journal of Medicinal Chemistry, 2015
- Structure of the mycobacterial ATP synthase F o rotor ring in complex with the anti-TB drug bedaquilineScience Advances, 2015
- ATP synthase in mycobacteria: Special features and implications for a function as drug targetBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2014
- Towards a new combination therapy for tuberculosis with next generation benzothiazinonesEMBO Molecular Medicine, 2014
- Antifungal, cytotoxic and SAR studies of a series of N-alkyl, N-aryl and N-alkylphenyl-1,4-pyrrolediones and related compoundsBioorganic & Medicinal Chemistry, 2011
- Synthesis and antimicrobial activity of some new N-acyl substituted phenothiazinesEuropean Journal of Medicinal Chemistry, 2009
- The Diarylquinoline TMC207 for Multidrug-Resistant TuberculosisNew England Journal of Medicine, 2009
- Fullerene Isoniazid Conjugate – A Tuberculostat with Increased Lipophilicity: Synthesis and Evaluation of Antimycobacterial ActivityChemical Biology & Drug Design, 2009
- From a Natural Product Lead to the Identification of Potent and Selective Benzofuran-3-yl-(indol-3-yl)maleimides as Glycogen Synthase Kinase 3β Inhibitors That Suppress Proliferation and Survival of Pancreatic Cancer CellsJournal of Medicinal Chemistry, 2009
- A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosisScience, 2005